Capital International Investors Astrazeneca PLC Transaction History
Capital International Investors
- $590 Billion
- Q3 2025
A detailed history of Capital International Investors transactions in Astrazeneca PLC stock. As of the latest transaction made, Capital International Investors holds 25,052,520 shares of AZN stock, worth $2.24 Billion. This represents 0.33% of its overall portfolio holdings.
Number of Shares
25,052,520
Previous 31,404,983
20.23%
Holding current value
$2.24 Billion
Previous $2.19 Billion
12.42%
% of portfolio
0.33%
Previous 0.39%
Shares
33 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa21.2MShares$1.89 Billion0.6% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...